aracelir, Author at Ming Hsieh Institute - Page 2 of 4

An Ultrasound Activated Ultrasound Contrast Agent for Urinary Imaging

Investigators: Travis Williams, Andy Chang, Jesse Yen

Improving Immunotherapy in Breast Cancer Using Computational Modeling

Investigators: Stacey Finley, Evanthia Roussos Torres

Liquid Biopsy Predicts Metastatic Relapse in Primary Bladder Cancer Patients

Investigators: Peter Kuhn, Hooman Djaladat, Jeremy Mason

Low-Cost “Smart” mHealth System for Predicting Future Likelihood of Vaso-Occlusive Pain Crisis: Moving Towards Personalized Medicine in Sickle Cell Disease

Investigators: Michael Khoo, Thomas Coates, Saranya Veluswamy

Therapeutic Application of Urinary Extracellular Vesicles for Autosomal Dominant Polycystic Kidney Disease

Investigators: Eun Ji Chung, Kenneth Hallows

A next-generation MR-Linac imaging strategy for abdominal MR-guided radiotherapy

Investigators: Zhaoyang Fan; Krishna Nayak

Developing novel immunotherapy for colorectal cancer

Investigators: Yong Zhang; Heinz-Josef Lenz; Alan Epstein

Development of a novel multimodal molecular imaging approach to guide intra operative tumor resection and post-operative treatment planning

Investigators: Cristina Zavaleta; Manju Aron; Uttam Sinha; Scott Fraser

Image enhancement for low-field MRI

Investigators: Justin Haldar; Jay Acharya

Molecular imaging of lymph node metastases in prostate cancer using targeted nanoparticles

Investigators: Eun Ji Chung; Mitchell Gross; Russell Jacobs; Alex Wong